Nuvation Scores First FDA Nod With Oral Lung Cancer Drug

Nuvation Bio’s first approved product is Ibtrozi, a CNS-active ROS1 inhibitor that in pivotal studies showed high rates of treatment response in patients with non-small cell lung cancer.